Our data exhibit that CK18 is persistently expressed in a variety of epithelial cancers, Particularly adenocarcinomas. each loss of CK18 expression in cancers derived from CK18 optimistic precursor cells and neo-expression in malignancies derived from CK18 constructive precursors are usually linked to unfavorable tumor phenotype and condition resul